Normal allele: CC
Antioxidant defence enzyme gene breakdown.
Polymorphism rs662 is related to topics like this:
Research and publications:
8098250 The molecular basis of the human serum paraoxonase activity polymorphism.
9385372 The Arg192 isoform of paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese.
11810302 Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
11888590 Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip.
15241482 Paraoxonase 1 polymorphisms and survival.
17702780 Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.
17975119 Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study.
18034366 Lack of replication of genetic associations with human longevity
18203168 Folate and one-carbon metabolism gene polymorphisms and their associations with oral facial clefts
18282109 Adaptations to climate in candidate genes for common metabolic disorders
18618303 A common haplotype within the PON1 promoter region is associated with sporadic ALS.
18682580 Oxidative response gene polymorphisms and risk of adult brain tumors.
18708400 Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
18787196 Segment-specific genetic effects on carotid intima-media thickness: the Northern Manhattan study.
19104460 Interaction between PON1 and population density in amyotrophic lateral sclerosis.
19321847 A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.
19357718 Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women.
19587357 A systematic meta-analysis of genetic association studies for diabetic retinopathy
20031584 Genetics of atherothrombotic and lacunar stroke
20056567 Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes.
20140262 Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth.
20381198 Lack of association of PON polymorphisms with sporadic ALS in an Italian population.
20488557 Decreased serum arylesterase activity in autism spectrum disorders.
20616999 Usefulness of Mendelian randomization in observational epidemiology.
20856122 Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis.
21146954 Genes and abdominal aortic aneurysm
21170047 Paraoxonase-1 is a major determinant of clopidogrel efficacy.
21609220 Genetics of age-related macular degeneration: current concepts, future directions.
21881565 Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.
21894447 Are centenarians genetically predisposed to lower disease risk?
21918509 Pharmacogenomics: application to the management of cardiovascular disease.
21921273 Cardiovascular pharmacogenomics.
22133529 Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis.
22187169 A new PCR method: one primer amplification of PCR-CTPP products.
22190063 Predicting clopidogrel response using DNA samples linked to an electronic health record.
22303384 Whole genome sequences of a male and female supercentenarian, ages greater than 114 years.
22427735 Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response.
22553514 Single nucleotide polymorphisms of metabolic syndrome-related genes in primary open angle glaucoma.
22577559 Novel associations of nonstructural Loci with paraoxonase activity.
22723959 Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population.
22792358 Association between genetic variants in DNA and histone methylation and telomere length.
22884547 Association analysis of PON polymorphisms in sporadic ALS in a Chinese population.
22938532 Sequencing and analysis of a South Asian-Indian personal genome.
23319877 Association between ABCB1 Polymorphisms and Ischemic Stroke in Korean Population.
23697979 Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?
23797323 Pharmacogenomics of anti-platelet and anti-coagulation therapy.
23903878 Prenatal methylmercury exposure and genetic predisposition to cognitive deficit at age 8 years.
24100645 Association of paraoxonase gene polymorphisms with diabetic nephropathy and retinopathy.